Real-time enrollment status for this metastatic malignant neoplasm clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 6:36 AM UTC
| NCT Number | NCT06240728 |
| Recruiting Status | Recruiting |
| Condition | Metastatic Malignant Neoplasm |
| Phase | Clinical Trial |
| Target Enrollment | 144 participants |
| Active Locations | 6 sites in the US |
| Sponsor | NextPoint Therapeutics, Inc. |
| Last Updated on CT.gov | June 27, 2025 (Jun 27, 2025) |
As of July 13, 2026: Clinical trial NCT06240728 is currently recruiting participants. This clinical trial study for metastatic malignant neoplasm is actively seeking new participants at 6 locations across the United States. The study is sponsored by NextPoint Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06240728 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 6 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06240728 was last updated Jun 27, 2025 (June 27, 2025). HelloStudys verifies this status automatically.